Transcriptional regulation: Kamikaze activators  by Thomas, Dominique & Tyers, Mike
Dispatch R341
Transcriptional regulation: Kamikaze activators
Dominique Thomas* and Mike Tyers†
Transcription factors are often targeted for rapid
degradation by the ubiquitin–proteasome system.
Recent evidence points to a correlation between the
potency and instability of transcriptional activators,
suggesting a possible direct role for ubiquitin-
dependent proteolysis in transcriptional activation.
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The ubiquitin proteolytic system often attenuates cellular
responses to extracellular cues by rapidly degrading key
signalling proteins, from cell surface receptors to nuclear
transcription factors. Ubiquitin is covalently attached to
substrate proteins by a conserved enzymatic cascade,
E1fi E2fi E3, which assembles a polyubiquitin chain on
the substrate, leading to its capture and rapid degradation
by the 26S proteasome [1]. The crucial step in the
pathway is substrate recognition, carried out by the E3
ubiquitin ligases, which bind to a specific region on the
substrate termed a degron. Although the ubiquitin-depen-
dent elimination of numerous transcription factors is well
documented, recent studies suggest that the most potent
transcriptional activators are highly unstable, perhaps as a
very consequence of their efficient interaction with the
transcriptional machinery.
In eukaryotes, activation of transcription by RNA
polymerase II requires the coordinated assembly of a
complex protein machinery, composed of the RNA
polymerase II holoenzyme, general transcription factors,
chromatin remodeling activities, histone acetylases and
gene-specific transcriptional activators [2]. Activators have a
modular structure, typically comprising a DNA binding
domain that recognizes enhancer sequence elements in the
target gene promoter, and one or more activation domains
that stimulate RNA polymerase II-dependent gene tran-
scription. Domain swap experiments have revealed that
activation domains are functionally autonomous units able
to stimulate RNA polymerase II activity when fused to a
heterologous DNA binding domain. Activation domains are
loosely classified by amino acid composition as acidic, gluta-
mine-rich, proline-rich and isoleucine-rich. In extreme
cases, a stretch of six to eight amino acids is sufficient for
transcriptional activation. Activation domains make direct
protein–protein contacts with RNA polymerase II-associ-
ated factors and are believed to stimulate transcription by
directing the recruitment of the RNA polymerase II
holoenzyme to promoter regions on DNA [3]. 
An initial link between activator degradation and
transcriptional potency arose from a study of the Myc
transcription factor, a powerful regulator of cell prolifera-
tion that is normally held in check by ubiquitin-depen-
dent proteolysis. Deletion analysis of Myc showed that
its activation domain and degron regions are tightly
super-imposed [4]. A subsequent literature survey
revealed overlapping activation domains and degrons in
numerous other transcription factors [5]. To evaluate the
possible functional significance of the destabilizing
regions in activators, Salghetti et al. [5] undertook a sys-
tematic analysis of various activation domains fused to
the same Gal4 DNA binding domain. Independently,
while in the course of dissecting transcription factor
structure/function relationships, Molinari et al. [6] exam-
ined a similar panel of chimeric activators. Both studies
unveiled a striking coincidence of activator potency and
instability. In particular, the most potent class of transcrip-
tional activators, those rich in acidic residues, are by far
the most unstable. In contrast, transcription factors with
weak proline-rich or glutamine-rich activation domains are
much more stable.
The relationship between activator potency and instabil-
ity was corroborated by a detailed analysis of synthetic
activation domains, consisting of multiple tandem copies
of a short acidic fragment derived from the potent activa-
tion domain of the HSV viral protein VP16 [5,6]. As the
copy number of the VP16 fragment is increased, so is
transcriptional activation and, concomitantly, instability
of the chimeric activator. Importantly, single point muta-
tions in the VP16 sequence that abolish transcriptional
activation strongly stabilize the chimeric activators. In
addition, recruitment of the activator to DNA appears
necessary for proficient degradation [6]. The various
chimeric activators are targeted by the ubiquitin system,
as shown by the accumulation of ubiquitinated forms of
the activators in cells treated with proteasome inhibitors.
Moreover, the extent of activator ubiquitination is pro-
portional to the number of VP16 repeats [5]. Intrigu-
ingly, in pursuing the activation domain–degron
connection, Salghetti et al. found that PEST-rich degron
domains derived from yeast G1 cyclins, which do not
normally participate in transcriptional activation, also
function as activation domains when fused to the Gal4
DNA binding domain [5].
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A recent study of the Microphthalmia (Mi) transcription
factor by Wu et al. [7] lends further support to the idea that
potent activation domains can simultaneously serve as
signals for proteolysis. Mi is an essential effector of the
c-Kit receptor tyrosine kinase during melanocyte develop-
ment. Activation of c-Kit by its ligand Steel results in
phosphorylation of Mi by two downstream kinases in the
signaling pathway, mitogen activated protein (MAP)
kinase and Rsk. In turn, phosphorylated Mi recruits a tran-
scriptional coactivator, p300/CBP, to target gene promot-
ers, thereby activating transcription. Once phosphorylated,
Mi is also rapidly degraded by the ubiquitin–proteasome
system. Mutation of the two relevant serine residues on
Mi that are normally phosphorylated abolishes Mi-depen-
dent transcription without affecting the ability of Mi to
bind DNA. And correspondingly, the mutant version of
Mi is completely refractory to signal-induced degradation.
Taken together, these results argue that transcriptional
activation and activator degradation are closely coupled
events. It is worth emphasizing that this relationship is the
exact converse of that observed in numerous other circum-
stances, in which inhibition of activator degradation leads
to an increase in transcription. A notable example of the
latter is the stabilization of p53 and concomitant activation
of p53-dependent transcription during the DNA damage
response [8]. How might these superficially disparate find-
ings be reconciled? A key difference between the two
processes lies in the context of the degradation pathways.
On the one hand, the many dedicated pathways that
signal turnover of specific activators do so independently
of transcriptional status, while on the other hand, the insta-
bility of strong activators apparently requires a productive
interaction with the RNA polymerase II machinery. That
is, in addition to an intact activation domain, proper recruit-
ment of the activator to the promoter is necessary for effi-
cient degradation [6]. In perhaps the simplest model, the
RNA polymerase II holoenzyme and/or its cofactors might
bridge the activator to the ubiquitination machinery
(Figure 1). In a formal sense, the RNA polymerase II
machinery would serve as the substrate recognition compo-
nent of an E3 ubiquitin ligase.
If this notion is correct, then it should be possible to detect
an activator-specific ubiquitin ligase activity associated
with the RNA polymerase II holoenzyme or a coactivator
complex. A number of components of the ubiquitin–pro-
teasome pathway have been detected in association with
the RNA polymerase II machinery, including E3 ubiquitin
ligases, ubiquitin hydrolases and subunits of the protea-
some (see citations in [5–7]). Indeed, an age-old puzzle is
the association of mono-ubiquitinated forms of histone
H2A with actively transcribed regions of the genome [9].
In a recent intriguing example, the HECT domain E3
enzyme Tom1 was found to be required for efficient tran-
scription of several genes in yeast and physically associates
with SAGA, a multisubunit histone acetylase [10]. Perhaps
not by chance, the SAGA complex is preferentially
recruited by acidic activation domains [11]. Whether it is
Tom1 or some other E3 that catalyzes ubiquitination of
acidic activators remains to be determined. Delineation of
the degradation pathway will also await the identification
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Figure 1
Ubiquitin-dependent proteolysis of potent transcriptional activators.
(a) A strong acidic activation domain (AD) binds to an enhancer
element (ENH) via a DNA binding domain (DBD). The activation
domain is envisaged to recruit the basal transcription apparatus,
consisting of the RNA polymerase II holoenzyme (RNA pol II) and
associated general transcription factors, including TFIID, which
binds to the TATA element in the core promoter. It is not known at
what point or by what means the ubiquitination machinery
(E1/E2/E3) is recruited to the promoter. (b) Assembly of the
transcriptional initiation complex leads to ubiquitination of the
activator and its rapid degradation by the 26S proteasome. Possible
coupling of activator degradation to elongation is indicated by
phosphorylation of the CTD and/or the activator by various CTD
kinases. (c) Speculative role for activator degradation in elongation
and possible requirement for continuous reloading of newly
synthesized activators.
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of the relevant E2 enzyme, and other factors that might
regulate the dynamics of ubiquitin conjugation to activa-
tors, such as ubiquitin hydrolases. Finally, it will be of con-
siderable interest to determine if components of the
general transcriptional machinery are also degraded in
concert with intense transcriptional activity.
But why destroy the very factors dedicated in the first
place to high level transcription? The obvious possibility
is to provide a fail-safe mechanism against unbridled, and
hence potentially deleterious, levels of transcription.
Similarly, the intrinsic instability of potent activators
might allow the transcriptional apparatus to be quickly re-
programmed upon a change in cellular state without the
need for degradation pathways tailored to each and every
activator. But perhaps the effect has deeper origins.
Another unique property of potent acidic activators is their
ability to stimulate transcriptional elongation and down-
stream mRNA processing events [12]. Might this coinci-
dence reflect an unsuspected liaison between efficient
elongation and transcription factor degradation? 
There is a good deal of evidence indicating that elongation
requires phosphorylation of the extensive carboxy-terminal
heptad repeat (CTD) domain of the large subunit of RNA
polymerase II, a complex event carried out by several resi-
dent cyclin-dependent kinases of the transcriptional
machinery [13]. It is possible that activator degradation
might arise either as a consequence of CTD phosphoryla-
tion, perhaps through recruitment of E3 activity to the RNA
polymerase II holoenzyme (for example [14]), or even as a
direct result of activator phosphorylation by one or more
RNA polymerase II associated kinases (for example [15]).
The ubiquitination machinery often specifically targets
phosphorylated substrates and in fact, the yeast G1 cyclin
degrons that act as synthetic activation domains when fused
to a DNA binding domain are normally targeted for degra-
dation by phosphorylation [5]. It is just conceivable that
such degrons might recruit their cognate E3 enzymes to
ectopically stimulate the transcriptional machinery.
What specific role could activator degradation play in
transcriptional elongation? As an alternative to models in
which elongation depends on transactivator-RNA
polymerase II holoenzyme dissociation, one might envisage
proteolysis of the promoter-bound activator as a way of
decoupling the engaged RNA polymerase II complex from
the promoter (Figure 1). In this scenario, on-going transcrip-
tion would entail continuous reloading of newly synthesized
transcription factors, a possibility that has yet to be exam-
ined in vivo. A rapid turnover of promoter-bound transcrip-
tion factors would certainly lend an appealing dynamic edge
to the process of RNA polymerase II holoenzyme recruit-
ment. Flights of fancy aside, ubiquitination seems set to
claim a place alongside acetylation, methylation and phos-
phorylation on the list of the biochemical events intimately
associated with RNA polymerase II-dependent transcrip-
tion. So much the worse for the potent activators that are
indeed the divine wind of high-level transcription.
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